Yunheng Li

Yunheng Li


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
JWJianping Wu
Jianping Wu
YLYunheng Li
Yunheng Li
QHQiaojun He
Qiaojun He
XYXiaochun Yang
Xiaochun Yang
Currently, chemotherapy is the main treatment for tumors, but there are still problems such as unsatisfactory chemotherapy results, susceptibility to drug resistance, and serious adverse effects. Natural compounds have numerous pharmacological activities which are important sources of drug discovery for tumor treatment. The combination of chemotherapeutic drugs and natural compounds is gradually becoming an important strategy and development direction for tumor treatment. In this paper, we described the role of natural compounds in combination with chemotherapeutic drugs in synergizing, reducing drug resistance, mitigating adverse effects and related mechanisms, and providing new insights for future oncology research.

1 December 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YLYunheng Li
Yunheng Li
SSShenghu Sang
Shenghu Sang
WRWeijie Ren
Weijie Ren
YPYuqiong Pei
Yuqiong Pei
YBYaoyao Bian
Yaoyao Bian
HSHaopeng Sun
Haopeng Sun

27 November 2025 in Phytomedicine
Verified
Journal Article
Open access
YLYunheng Li
Yunheng Li
MYMinghua Ye
Minghua Ye
QHQiaojun He
Qiaojun He
BYBo Yang
Bo Yang
PLPeihua Luo
Peihua Luo
XYXiaochun Yang
Xiaochun Yang
Metabolic dysfunction-associated steatotic liver disease (MASLD) represents a global health challenge with limited therapeutic options. This study identified leucocyanidin (Leuc), a bioactive flavonoid from the traditional herb Crataegus pinnatifida (hawthorn), as a novel dual-target therapeutic agent against MASLD. We evaluated the effects of Leuc on a mouse model induced by a 60% high-fat diet and a cell model induced by free fatty acids (FFA). Compared to the model group, Leuc treatment dose-dependently significantly reduced liver weight, serum levels of TG and TC, hepatic inflammation markers (IL-6 and TNF-α), as well as cellular TG content. Histological and fluorescence analyses revealed a significant reduction in lipid droplet accumulation. Mechanistically, Leuc exerted its protective effects through two major pathways: (1) By activating the NRF2 antioxidant axis, Leuc attenuated oxidative stress-induced mitochondrial dysfunction and restored fatty acid β-oxidation capacity; (2) Through direct allosteric binding to AMPK, Leuc suppressed fatty acid uptake, inhibited lipogenesis, and enhanced mitochondrial fatty acid transport. These coordinated mechanisms reestablished hepatic lipid homeostasis, positioning Leuc as a promising dual-target natural compound for MASLD intervention through simultaneous AMPK/NRF2 activation.

26 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
YLYunheng Li
Yunheng Li
HLHui Li
Hui Li
QHQiaojun He
Qiaojun He
XYXiaochun Yang
Xiaochun Yang
Hepatocellular carcinoma (HCC), the most prevalent subtype of liver cancer, is the second main reason for cancer-related deaths worldwide. In recent decades, sufficient evidence supported that immunotherapy was a safe and effective treatment option for HCC. However, tolerance and frequent recurrence and metastasis occurred in patients after immunotherapy due to the complicated crosstalk in the tumor immunosuppressive microenvironment (TIME) in HCC. Therefore, elucidating the TIME in HCC and finding novel modulators to target TIME for attenuating immune suppression is critical to optimize immunotherapy. Recently, studies have shown the potentially immunoregulatory activities of natural compounds, characterized by multiple targets and pathways and low toxicity. In this review, we concluded the unique role of TIME in HCC. Moreover, we summarized evidence that supports the hypothesis of natural compounds to target TIME to improve immunotherapy. Furthermore, we discussed the comprehensive mechanisms of these natural compounds in the immunotherapy of HCC. Accordingly, we present a well-grounded review of the naturally occurring compounds in cancer immunotherapy, expecting to shed new light on discovering novel anti-HCC immunomodulatory drugs from natural sources.